Retrophin RTRX 深 沪
已收盘 11-18 16:00:00 美东时间
24.25
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 24.25
- 总市值 12.38亿
- 52周最高 24.96
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.98
- 委 比 0.00%
- 总股本 5105.18万
- 历史最高 37.04
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.90
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Rent the Runway Announces Growth Recapitalization and Strategy Expansion
Rent the Runway (RTR) announces a recapitalization with partners APS, STORY3 Capital Partners, and Nexus Capital Management to strengthen its balance sheet, reduce debt, and lower interest expenses. The transaction involves APS converting $243M of debt into common equity, while partners contribute $20M in new capital. RTR's debt will drop to $120M with extended maturity to 2029. The company will continue as a public entity, aiming to enhance cust...
08-21 12:00
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
Allarity Therapeutics appointed Jeff Ervin as its new Chief Financial Officer, succeeding Alexander Epshinsky. Ervin brings over 20 years of leadership experience in healthcare and biotech, including roles at DayDayCook and IMAC Holdings. He holds an MBA from Vanderbilt University and currently serves on the board of Cingulate Inc. Ervin's expertise in public company management and financial strategy is expected to support Allarity's clinical dev...
07-07 12:00
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.
07-04 21:20
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
Pharma bro Martin Shkreli predicted Cassava Sciences stock would fall and the company would miss primary endpoints for its Phase 3 trial.
2024-11-26 00:07
BRIEF-Retrophin Announces Corporate Name Change To Travere Therapeutics Inc
Nov 16 (Reuters) - Retrophin Inc : * RETROPHIN ANNOUNCES CORPORATE NAME CHANGE...
2020-11-16 21:05
BRIEF-Retrophin Reports Q2 Loss Per Share $0.58
July 30 (Reuters) - Retrophin Inc : * RETROPHIN REPORTS SECOND QUA...
2020-07-31 05:19
BRIEF-Retrophin Reports Q2 Loss Per Share $0.58
July 30 (Reuters) - Retrophin Inc : * RETROPHIN REPORTS SECOND QUA...
2020-07-31 05:19
Did Hedge Funds Make The Right Call On Retrophin Inc (RTRX) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plow...
2020-07-20 22:37
Retrophin Inc (RTRX): Hedge Funds Sticking Around
In this article you are going to find out whether hedge funds think Retrophin I...
2020-06-17 17:55
Retrophin to Present at the Jefferies 2020 Virtual Healthcare Conference
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) toda...
2020-05-28 04:05
